PF-04457845
PF-04457845 is a drug that is currently under investigation for its potential therapeutic uses. It is a highly potent and selective inhibitor of fatty acid amide hydrolase (FAAH), an enzyme that breaks down endocannabinoids in the body. By inhibiting FAAH, PF-04457845 increases the levels of endocannabinoids, which are involved in a variety of physiological processes including pain, mood, and inflammation.
History[edit | edit source]
PF-04457845 was developed by Pfizer, a multinational pharmaceutical company. The drug was initially investigated for its potential use in the treatment of osteoarthritis pain, but these studies were discontinued. More recently, PF-04457845 has been studied for its potential use in the treatment of cannabis dependence.
Mechanism of Action[edit | edit source]
PF-04457845 works by inhibiting the enzyme FAAH. This enzyme is responsible for breaking down endocannabinoids, which are naturally occurring compounds in the body that bind to the same receptors as the active components of cannabis. By inhibiting FAAH, PF-04457845 increases the levels of endocannabinoids in the body, which can have a variety of effects depending on the specific endocannabinoid and its receptors.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to investigate the potential therapeutic uses of PF-04457845. These trials have primarily focused on the drug's potential use in the treatment of cannabis dependence. In a phase II clinical trial, PF-04457845 was found to reduce cannabis withdrawal symptoms and cannabis use in dependent individuals.
Side Effects[edit | edit source]
As with any drug, PF-04457845 has the potential to cause side effects. In clinical trials, the most commonly reported side effects were mild and included headache, nausea, and dizziness.
Future Research[edit | edit source]
Future research on PF-04457845 will likely continue to focus on its potential use in the treatment of cannabis dependence. Additional studies may also investigate other potential therapeutic uses for the drug, such as in the treatment of pain or inflammation.
| PF-04457845 Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
